D-1142-2023 Class III
FDA drug recall D-1142-2023 was initiated by Lundbeck LLC on Aug 17, 2023 and is designated Class III. Reason for recall: Cross contamination with other products Affected quantity: 10,543 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 6, 2023
- Initiation Date
- Aug 17, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,543 cartons
Product description
Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65
Reason for recall
Cross contamination with other products
Distribution pattern
Nationwide within the U.S.
Code information
Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 .
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1142-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026